RG-1511
- Generic Name
- RG-1511
A Multiple Ascending Dose Study of R1511 in Patients With Type 2 Diabetes Mellitus.
- First Posted Date
- 2007-08-17
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 41
- Registration Number
- NCT00517465
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath